Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0231 | 0.116 | 0.2963 |
Onchocerca volvulus | 0.0231 | 0.116 | 0.2097 | |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0248 | 0.1313 | 0.2724 |
Echinococcus multilocularis | semaphorin 5B | 0.0231 | 0.116 | 0.2407 |
Brugia malayi | Sema domain containing protein | 0.0231 | 0.116 | 0.2407 |
Loa Loa (eye worm) | hypothetical protein | 0.0308 | 0.1851 | 0.3839 |
Brugia malayi | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Schistosoma mansoni | hypothetical protein | 0.0231 | 0.116 | 0.2963 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Brugia malayi | Plexin repeat family protein | 0.054 | 0.3916 | 0.8123 |
Loa Loa (eye worm) | hypothetical protein | 0.054 | 0.3916 | 0.8123 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0101 | 0 | 0.5 |
Echinococcus granulosus | semaphorin 5B | 0.0231 | 0.116 | 0.116 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0137 | 0.0318 | 1 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0231 | 0.116 | 0.2407 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 0 | 0.5 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0196 | 0.0846 | 0.1195 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0101 | 0 | 0.5 |
Onchocerca volvulus | 0.054 | 0.3916 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 0 | 0.5 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0101 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0137 | 0.0318 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 0 | 0.5 |
Loa Loa (eye worm) | plexin A | 0.0641 | 0.4821 | 1 |
Echinococcus multilocularis | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 0 | 0.5 |
Echinococcus multilocularis | plexin a4 | 0.0641 | 0.4821 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Echinococcus granulosus | plexin a4 | 0.0641 | 0.4821 | 0.4821 |
Schistosoma mansoni | plexin | 0.054 | 0.3916 | 1 |
Echinococcus granulosus | semaphorin 1A | 0.0231 | 0.116 | 0.116 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0231 | 0.116 | 0.2407 |
Brugia malayi | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Schistosoma mansoni | plexin | 0.0308 | 0.1851 | 0.4727 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0101 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.116 | 0.2407 |
Schistosoma mansoni | semaphorin 5-related | 0.0231 | 0.116 | 0.2963 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0101 | 0 | 0.5 |
Brugia malayi | Sema domain containing protein | 0.0231 | 0.116 | 0.2407 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0308 | 0.1851 | 0.4727 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0248 | 0.1313 | 0.2724 |
Brugia malayi | plexin A | 0.0641 | 0.4821 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | > 100000 nM | Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay | ChEMBL. | 21117646 |
Ki (binding) | > 100000 nM | Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells | ChEMBL. | 21117646 |
T1/2 (ADMET) | = 5.5 hr | Half life in human serum by LC/MS and RP-HPLC method | ChEMBL. | 21117646 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.